Allison Coker, Ph.D. serves as the Associate Director of Regulatory Affairs at MAPS PBC where she guides the North American regulatory strategy to develop and deliver innovative products to marketing approval, in alignment with global business strategy. Dr. Coker serves as Regulatory Lead on cross-functional Core teams to communicate regulatory requirements and ensure optimal execution of regulatory strategy and study governance. In this role Dr. Coker provides expertise, sound decision making, and guidance (both strategic and operational) to develop and optimize the regulatory strategy across MAPS clinical development programs.
Dr. Coker was trained as neuroscientist with a multidisciplinary background in behavioral pharmacology studying motivation, addiction, and stress across diverse research methodologies in both preclinical and clinical research settings. She earned her bachelor’s degree in Neuroscience and Behavioral Biology from Emory University and a doctorate in Neuroscience from the University of California, San Francisco (UCSF). Prior to joining MAPS PBC, Dr. Coker worked as a Program Manager for the Institute for Translational Neuroscience, a research consortium at UCSF focused on conducting translational and clinical research to develop novel treatment strategies for PTSD and alcohol and substance use disorders.
Dr. Coker is excited by both the therapeutic potential and regulatory challenges of making MDMA a medicine and enjoys leveraging her experience to support data-driven advancement of MAPS’ clinical development program.